Global portfolio companies as of December 31, 2025. Real estate assets of March 31, 2026.
This is not an offer to sell or investment advice. Investing involves risks, including loss of capital. Past performance does not predict future returns, and not all strategies have existed for the stated 40 years. Please review performance in offering materials before investing.
Based on total AUM.
Blackstone data as of December 31, 2025. Market data sourced from public filings and fund websites, as of December 31, 2025, and is latest available for the peer set. Based on Blackstone’s analysis of publicly available data of the total net asset value (NAV) of alternative investment firms that offer solutions for individual (non-institutional) investors to invest in private equity, real estate, infrastructure, and private credit through U.S.-domiciled semi-liquid, perpetual private market funds (including non-traded REITs and non-traded BDCs). Blackstone’s analysis compares the total NAV as of December 31, 2025 for Blackstone’s non-traded REIT, non-traded BDC products, infrastructure and private equity vehicles for individual investors, to the total NAV as of December 31, 2025 of comparable products offered by alternative investment firms. This selection of alternative investment firms for comparison may not be representative of all in the category or sector. Private placement REIT and BDC products have been excluded from the dataset. Investing involves risks, including loss of capital.
World’s largest owner of commercial real estate based on estimated market value per Real Capital Analytics, as of December 31, 2025.
As of April 30, 2026.
Past performance does not predict future returns. The inception dates for the Class S, I, T and D shares are January 1, 2017, January 1, 2017, June 1, 2017 and May 1, 2017, respectively. The inception date for the Class S-2, T-2 and D-2 shares is August 5, 2025. The foregoing reflects the percent change in the NAV per share from the beginning of the applicable period, plus the amount of any distribution per share declared in the period.
All returns shown assume reinvestment of distributions pursuant to BREIT’s distribution reinvestment plan, are derived from unaudited financial information, and are net of all BREIT expenses, including general and administrative expenses, transaction-related expenses, management fees, performance participation allocation, and share class-specific fees, but exclude the impact of early repurchase deductions on the repurchase of shares that have been outstanding for less than one year. Returns listed as (with sales load) reflect the returns after the maximum upfront selling commission and dealer manager fees. Returns listed as (no sales load) exclude upfront selling commissions and dealer manager fees. With sales load returns assume payment of the maximum upfront sales charge at initial subscription (3.5% for Class S, Class S-2, Class T and Class T-2 shares; 1.5% for Class D and Class D-2 shares). The sales charge for Class D shares became effective May 1, 2018. The sales charge for Class S-2, T-2, and D-2 shares became effective August 5, 2025.
The returns have been prepared using unaudited data and valuations of the underlying investments in BREIT’s portfolio, which are estimates of fair value and form the basis for BREIT’s NAV. Valuations based upon unaudited reports from the underlying investments may be subject to later adjustments, may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. As return information is calculated based on NAV, return information presented will be impacted should the assumptions on which NAV was determined prove to be incorrect. Please see
https://www.breit.com/performance, including “Use of Leverage”, for additional information about BREIT’s performance.
Private Equity International, as of June 2025, based on capital raised between January 1, 2011, and December 31, 2024.
As of March 31, 2026.
As of March 31, 2026.
As of April 30, 2026.
Past performance does not predict future returns. Inception Date for Class I and S shares: January 7, 2021. Inception date for Class D shares: May 1, 2021. Total Net Return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested) divided by the beginning NAV per share. Returns greater than one year are annualized.
All returns shown are derived from unaudited financial information and are net of all BCRED expenses, including general and administrative expenses, transaction related expenses, management fees, incentive fees, and share class specific fees, but exclude the impact of early repurchase deductions on the repurchase of shares that have been outstanding for less than one year. Inception-to-date (“ITD”) returns for the other class shares are as follows. Class S (without / with upfront placement fees or brokerage commissions) shares: 8.4%/7.6%; Class D (without / with upfront placement fees or brokerage commissions) shares: 8.6%/8.3%. Class S and Class D listed as (With Upfront Placement Fee or Brokerage Commissions) reflect the returns after the maximum upfront placement fees (3.5% for Class S and 1.5% for Class D). Class S and Class D listed as (No Upfront Placement Fee or Brokerage Commissions) excludes upfront placement fees. Class I does not have upfront placement fees.
The returns have been prepared using unaudited data and valuations of the underlying investments in BCRED’s portfolio, which are estimates of fair value and form the basis for BCRED’s NAV. Valuations based upon unaudited reports from the underlying investments may be subject to later adjustments, may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. Please see
https://www.bcred.com/performance, including “Use of Leverage”, for additional information about BCRED’s performance.
As of April 30, 2026. Past performance does not predict future returns. Inception date for Class I shares: May 1, 2025. Inception date for Class I Advisory and Class S shares: July 1, 2025. Total return is calculated assuming a purchase of common share at the opening on the first day and a sale at closing on the last day of each period reported. Dividends and distributions are assumed for purposes of this calculation to be reinvested at prices obtained under the Fund’s distribution reinvestment plan. The Adviser waived the management fee in full for the six-month period beginning from the date the Fund completed its first sale of shares in its public offering. Without this waiver, returns would be lower. Returns greater than one year are annualized. All returns shown are derived from unaudited financial information and are net of all BMACX expenses, including general and administrative expenses, transaction related expenses, management fees, incentive fees, and share class specific fees, as applicable. Past performance does not predict future returns. There can be no assurance that any Blackstone fund or investment will achieve its objectives or avoid substantial losses. The returns have been prepared using unaudited data and valuations of the underlying investments in BMACX’s portfolio, which are estimates of fair value and form the basis for BMACX’s NAV. Valuations based upon unaudited reports from the underlying investments may be subject to later adjustments, may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. See “Use of Leverage” in the “Additional Important Disclosures” section for additional information.
International Data Corporation (IDC), as of May 2024. 2024-2028 represent year-end estimates.
S&P Global (December 2025), EIA (December 2025). Reflects forecasted US electricity demand from 2025E-2040E. Princeton Net-Zero America (2024).
Lazard LCOE Report as of June 2025, and LevelTen Energy Report as of January 2025. Based on the fact that ~95% of the interconnection queue is renewables (wind and solar) and amount to $1.5B/GW to build in North America. Assumes 2600 gigawatts in the current transmission queue, per Lawrence Berkeley National Laboratory, as of January 2025.
US Census Bureau, as of December 31, 2025. Figures reflect trailing twelve-month values.
The annual funding gap is Blackstone Life Sciences’ estimate of the gap between the annual spread between the demand for medicine and device development capital and the supply of development capital from Biopharma and MedTech companies through R&D budgets. Data sources are Evaluate Pharma and Morgan Stanley, Market Update Presentation to Blackstone Life Sciences. January 2024.